Abstract

Aberrant activation of epithelial-mesenchymal transition (EMT) in carcinoma cells contributes to increased migration and invasion, metastasis, drug resistance, and tumor-initiating capacity. EMT is not always a binary process; rather, cells may exhibit a hybrid epithelial/mesenchymal (E/M) phenotype. ZEB1—a key transcription factor driving EMT—can both induce and maintain a mesenchymal phenotype. Recent studies have identified two novel autocrine feedback loops utilizing epithelial splicing regulatory protein 1 (ESRP1), hyaluronic acid synthase 2 (HAS2), and CD44 which maintain high levels of ZEB1. However, how the crosstalk between these feedback loops alters the dynamics of epithelial-hybrid-mesenchymal transition remains elusive. Here, using an integrated theoretical-experimental framework, we identify that these feedback loops can enable cells to stably maintain a hybrid E/M phenotype. Moreover, computational analysis identifies the regulation of ESRP1 as a crucial node, a prediction that is validated by experiments showing that knockdown of ESRP1 in stable hybrid E/M H1975 cells drives EMT. Finally, in multiple breast cancer datasets, high levels of ESRP1, ESRP1/HAS2, and ESRP1/ZEB1 correlate with poor prognosis, supporting the relevance of ZEB1/ESRP1 and ZEB1/HAS2 axes in tumor progression. Together, our results unravel how these interconnected feedback loops act in concert to regulate ZEB1 levels and to drive the dynamics of epithelial-hybrid-mesenchymal transition.

Highlights

  • We compared these transitions as mediated by the miR-200/Zinc finger E-box binding homeobox 1 (ZEB1)/epithelial splicing regulatory protein 1 (ESRP1)/hyaluronic acid synthase 2 (HAS2)/CD44 circuit, with the control case, i.e., when ZEB1 self-activation is not included through these detailed pathways but instead as in earlier modeling attempts

  • For certain SNAIL levels, cells can exhibit more than one phenotype and can spontaneously interconvert among one another, for instance, among E and M states in the {E, M} phase [green shaded region in Figs. 1(c) and 1(d)], among E, hybrid E/M, and M states in the {E, E/M, M} phase [brown shaded region in Figs. 1(c) and 1(d)], and among hybrid E/M and M states in the {E/M, M} phase [pink shaded region in Figs. 1(c) and 1(d)]. These results suggest that ZEB1 self-activation mediated by ESRP1/CD44 and HAS2/hyaluronic acid (HA)/CD44 axes should be considered integral to the dynamics of epithelial-hybrid-mesenchymal transition

  • Hyaluronan— known as hyaluronic acid (HA)—is a proteoglycan that forms a scaffold for the assembly of the extracellular matrix (ECM)

Read more

Summary

Introduction

The complex nonlinear behavior emerging from interconnected mechanical and chemical multi-scale regulatory feedback loops can modulate many parameters of aggressive cancer behavior such as metastasis, drug resistance, and tumor relapse.. Epithelial-mesenchymal transition (EMT) is a latent embryonic program that may become aberrantly activated during tumor progression and can regulate metastasis, drug resistance, evasion of the immune system, and tumor-initiation and relapse.. EMT can be induced by multiple micro-environmental conditions such as ECM stiffness and hypoxia which can activate one or more of EMT-driving transcription factors (EMT-TFs) such as ZEB (ZEB1/2), Snail (SNAI1/2), and Twist.. EMT-TFs such as ZEB1 can crosslink collagen in the ECM, altering mechanical stiffness of the ECM.. EMT acts as a hub in mediating the mechanochemical response of the tumor microenvironment (TME)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call